In Canada, we face critical barriers to truly person-centred HCV care: one important barrier is that people cannot start treatment in the same appointment when their diagnosis is made. This impedes our ability to bring HCV care to priority populations as we work towards eliminating viral hepatitis as a public health threat by 2030.
But it doesn't need to be this way.
Ideally, a patient could get tested for HCV, receive their diagnosis, and start treatment ALL on the same day. This happens in Egypt, Myanmar, and now in Australia — so why not in Canada? What policies and regulations need to change, and to what technology do we need access in order to be a world leader on this front?
Join us for a virtual panel discussion on November 24, bringing together clinical and community perspectives as we determine the path forward for Canada.